NASDAQ · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · SMALL CAP
Basel Medical Group Ltd. BMGL
2 fiscal years on record · SGD · FY2024 reported · SEC filings only
In brief
What this company does
Written from the business description in Basel Medical Group Ltd's annual report to the U.S. Securities and Exchange Commission, filed 13 March 2026. Every sentence was checked against that document before publication.
Growth
SGD 11.3M
Revenue, FY2024 · full 2-year series below
Revenue SGD M
Net income SGD M
FY2024 · Revenue 11.3 · Net income -10.6
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−94 cents
lost on every revenue dollar
Operating margin
Net margin
FY2024 · Net -94.0%
ROE
Not available in our data for this period.
The 2-year record
2 fiscal years
Every figure from documents filed with the SEC · SGD
row low → row highnegative
| Metric | 2024 | 2023 |
|---|---|---|
| Revenue SGD B | 0.0 | 0.0 |
| Operating income SGD B | · | · |
| EBITDA SGD B | · | · |
| Income tax SGD B | −0.0 | 0.0 |
| Net income SGD B | −0.0 | 0.0 |
| Free cash flow SGD B | −0.0 | 0.0 |
| EPS, diluted SGD | −0.57 | 0.13 |
| Dividend / sh SGD | · | · |
| Payout % | · | · |
| ROE % | · | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 1 failures in 8 reconciliationsAUDITED
Reconciled in 1 of 19 fiscal years. 68 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente1 failures
ActivityServices-Offices & Clinics of Doctors of Medicine
Listed onNASDAQ
Incorporated inoutside the United States — SEC code D8
Fiscal year endsJune 30
SEC categoryemerging growth company
Data on record since2023